The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering the older age of participants and comorbid conditions reported, the mean HbA1c, GMI, TIR, and TBR results (8.0%, 7.6%, 56%, and 1.0% at 6 months, respectively) demonstrate close adherence to established glycemic targets (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As with any laboratory test, HbA1c measurement has limitations (2,52).”
The cited source says what the claim attributes to it.
In the citing paper
“The greatest absolute risk reduction comes from improving very elevated glycemic levels, and a more modest reduction results from near normalization of plasma glucose levels (2,14).”
The cited source says what the claim attributes to it.
In the citing paper
“Glycemic management is primarily assessed with the HbA1c test, which was the measure used in trials demonstrating the bene fi ts of glucose lowering (2,52).”
The cited source says what the claim attributes to it.
In the citing paper
“Low and very low glucose events occurred at a low rate (mean of ∼1.3 and 0.2 events per person per week in the sixth month, respectively) and were in keeping with time below range meeting established standards (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Other parameters such as the mean percent time of sensor use and mean coefficient of variation (84% and 31% at 6 months, respectively) are also within established guidelines (23, 24, 38).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“The observed reduction in HbA1c did not compromise the population from meeting established hypoglycemia targets of < 4% and < 1% for percent time < 70 mg/dL (mean 1.0%) and < 54 mg/dL (mean 0.04%), respectively (22-24).”
From Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis (2025) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,002
Seget, S., Chobot, A. P., Rusak, E., Ochab, A., Bielawska, A., Polańska, J., & Jarosz-Chobot, P. A. (2023) · Technology and Health Care · doi:10.3233/thc-230490 · Cited by 7
Comparative Analysis of Predictive Interstitial Glucose Level Classification Models
Moser, O., Sourij, H., Lobanovs, S., Kistkins, S., Mihailovs, T., Pīrāgs, V., & Bļizņuks, D. (2023) · Sensors · doi:10.3390/s23198269 · Cited by 7
Deepchand, S., Balla, V., Eroukhmanoff, J., Sall, K. L., Romain, B., Lejeune, M., Penfornis, A., & Amadou, C. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0379 · Cited by 7
Association of glycemic variability and time in range with lipid profile in type 1 diabetes
Castelo, M. I. S., Neves, C., Neves, J. S., & Carvalho, D. M. (2023) · Endocrine · doi:10.1007/s12020-023-03464-x · Cited by 7
Predictors of lack of glycemic control in persons with type 2 diabetes
Louie, J. Z., Shiffman, D., Rowland, C. M., Kenyon, N. S., Bernal‐Mizrachi, E., McPhaul, M. J., & Garg, R. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-023-00160-7 · Cited by 8
Alão, S., Silva, T., Leite, A. P., do Rosário, M., Carvalho, C., Coelho, J., Ferreira, H. J., Ferreira, R., Abreu, J., Rosa, M., et al. (2024) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2024.04.011 · Cited by 7
JAK inhibitors: a new choice for diabetes mellitus?
Zhou, M., Shen, Q., & Li, B. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01582-2 · Cited by 9
Glycemic control of diabetic patients in two Family Health Units, Paraguay, 2018. Pilot study
Gabetta, J., Amarilla, A., Rivelli, R., Guillén, G., Estigarribia, L. C., Báez, J. A. C., Zárate, F. M., Hermosa, W. P., & Campuzano, H. J. (2019) · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · doi:10.18004/rvspmi/2312-3893/2019.06(01)21-030 · Cited by 7
Nocturia in Women With Type 2 Diabetes Mellitus
Wang, T.-T., Chung, M., Chien, H.-Y., Palmer, M. H., Liao, C.-H., & Liao, Y. (2020) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000000635 · Cited by 7
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Weisman (2021) · The Journal of Family Practice · doi:10.12788/jfp.0222 · Cited by 7
The effect of food access on type 2 diabetes control in patients of a New Orleans, Louisiana, clinic
Delk, J. A., Singleton, B. A., Al-Dahir, S., Kirchain, W. R., & Wheeler, J. B. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.05.001 · Cited by 7
Rigalleau, V., Larroumet, A., Ducos, C., Rigo, M., Barbet‐Massin, M., Majchrzak, C., Mohammedi, K., Baillet‐Blanco, L., Monlun, M., Arab, L. R., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108234 · Cited by 7
GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
Neumiller, J. J., Alicic, R. Z., & Tuttle, K. R. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2030034 · Cited by 7
Improving Care Coordination of Patients With Chronic Diseases
Ju, H.-H. (2022) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.06.011 · Cited by 7
Silva, A. N. A., Nicchio, I. G., da Silva, B. R., Martelli, M. G. G., Hidalgo, M. A. R., Nepomuceno, R., Theodoro, L. H., Cirelli, J. A., Orrico, S. R. P., Cirelli, T., et al. (2022) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2022.105529 · Cited by 7
Implementation of a pharmacist-led diabetes management service in an endocrinology clinic
Parsiani, R., Lundy, R., Ahmann, A., Joarder, F., & Castle, J. R. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.08.012 · Cited by 8
Zafar, A. S. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107442 · Cited by 7
Levels and correlates of risk factor control in diabetes mellitus –ELSA-Brasil
Chwal, B. C., dos Reis, R. C. P., Schmidt, M. I., Duncan, B. B., Barreto, S. M., & Griep, R. H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00961-3 · Cited by 8
Chan, S. P., Lim, L., Chan, J. C. N., & Matthews, D. R. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01386-5 · Cited by 8
Estremera, E., Beneyto, A., Cabrera, A., Contreras, I., & Vehı́, J. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107568 · Cited by 7
Dungan, K. M., Bardtrum, L., Christiansen, E., Eliasson, J., Mellbin, L., Woo, V. C., & Vilsbøll, T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01413-5 · Cited by 8
Disparities in brain health comorbidity management in intracerebral hemorrhage
Mayerhofer, E., Zaba, N. O., Parodi, L., Ganbold, A., Biffi, A., Rosand, J. M., Yechoor, N., & Anderson, C. D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1194810 · Cited by 7
Abbas, A. B., Hazeb, A., Al-Badani, R., Al-Thmary, B., Mokaram, R., Al-Najjar, S. M. H. A.-D., Mothna, S., Kssiam, A., Esmail, A., & Al-Rashidi, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-43973-3 · Cited by 7
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c
Aggarwal, R., Bhatt, D. L., Szarek, M. J., Cannon, C. P., McGuire, D. K., Inzucchi, S. E., Lópes, R. D., Davies, M. J., Banks, P. L., Pitt, B., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.050 · Cited by 7
Ahmad, N., Ansari, K. A., Alamoudi, M. K., Ullah, Z., Haque, A., & Ibrahim, H. O. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106096 · Cited by 7
Efficacy and Safety of Naproxen for Acute Pain
Weisman, S. R. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0064 · Cited by 8
Diabetes education and self-care behaviors in patients with diabetes in Mexico
Romo-Romo, A., Sarmiento-Moreno, A. L., Aguilar-Salinas, C. A., García-Ulloa, C., Gómez‐Velasco, D., Gómez-Munguía, L., Galán-Ramírez, G. A., Brito-Córdova, G. X., Gómez-Munguía, L., Janka-Zires, M., et al. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000115 · Cited by 7
Hassounah, G., Aljohani, A. H., Sharhani, R. A., Aljoulni, M. A., Robert, A. A., Goudah, A. H. A., & Turki, A. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102351 · Cited by 7
Park, I., Choi, K., Ahn, J., Kim, W., Lee, Y.-T., & Jeong, D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01687-2 · Cited by 8
The Expanding Use of Continuous Glucose Monitoring in Type 2 Diabetes
Dabbagh, Z., McKee, M. D., Pirraglia, P. A., Clements, K. M., Liu, F., Amante, D. J., Shukla, P., & Gerber, B. S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0536 · Cited by 7
Hudson, E. A., Davis, J. N., Haushalter, K., Tanaka, H., Dubois, S. K., Steinhardt, M. A., & Burgermaster, M. (2024) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2024.10.007 · Cited by 8
den Braber, N., Vollenbroek-Hutten, M. M. R., Teunissen, S. E. M., Oosterwijk, M. M., Kappert, K. D. R., & Laverman, G. D. (2024) · Nutrients · doi:10.3390/nu16203557 · Cited by 7
Komura, T., Bargagli-Stoffi, F. J., Shiba, K., & Inoue, K. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01215-y · Cited by 7
A Narrative Review on the Risk Factors and Healthcare Disparities of Type 2 Diabetes
Gkrinia, E. M. M., & Belančić, A. (2025) · Diabetology · doi:10.3390/diabetology6040025 · Cited by 8
Mahindra, M. P., Jie, M., Mapindra, M. P., Rehman, S., Vaughan, O. R., Hillman, S. L., David, A. L., & Siassakos, D. M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08016-x · Cited by 6
Rubab, H., Aziz, F., Gul, R. B., & Froelicher, E. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093798 · Cited by 8
Alrasheedi, A. (2024) · Endokrynologia Polska · doi:10.5603/ep.99519 · Cited by 6
Allaire, J. C., Dennis, C., Masturzo, A., & Wittlin, S. D. (2024) · JMIR Diabetes · doi:10.2196/58832 · Cited by 7
AlRasheed, A., Hashim, H., & Alrofaie, H. (2024) · Cureus · doi:10.7759/cureus.65545 · Cited by 6
Bayih, A., Dedefo, G., Kinde, S., Alem, M., Negesso, A. E., Baye, A., Abreham, A., Getaneh, A., Akalu, G. T., Bayable, A., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01665-7 · Cited by 12
Cuixart, G., Corcoy, R., & González, C. (2024) · HORMONES · doi:10.1007/s42000-024-00609-z · Cited by 9
Delgado, E., Morales, C., Abreu, C., Verdugo, A. A., Carbonell, A. M. P., González, A. C., Valero, J. A. G., López, V. G., Rasmussen, C. L., Scheuer, S. H., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16523 · Cited by 5
Lingow, S. E., & Guyton, J. E. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.02.028 · Cited by 6
Larry, M., Alizadeh, S., Naderi, S., Salekani, B., Mansournia, M. A., Rabizadeh, S., Esteghamati, A., & Nakhjavani, M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.015 · Cited by 6
Managing the Burden of Dementia-Related Delusions and Hallucinations
Small (2020) · The Journal of Family Practice · doi:10.12788/jfp.0065 · Cited by 6
Schulman‐Rosenbaum, R., Hadzibabic, N., Cuan, K., Jornsay, D. L., Wolff, E., Tiberio, A., Gottlieb, D., Davis, F., & Silverman, R. A. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.06.018 · Cited by 6
Fantahun, B., & Leulseged, T. W. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0144 · Cited by 7
Quansah, D. Y., Giorgi, S. D., Dizès, O. L., Camponovo, C., Benhalima, K., Cosson, E., & Puder, J. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14920 · Cited by 6
Fu, W., Yan, L., Hou, Z., Yu, Y., Zhang, W., Cui, R., Gao, F., Mo, D., Lou, X., Miao, Z., et al. (2022) · Journal of neurosurgery · doi:10.3171/2022.6.jns221103 · Cited by 6
Talbo, M. K., RABASA-LHORET, R. P. R., Yale, J., Peters, T. M., & Brazeau, A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110080 · Cited by 6
Diabetic retinopathy as a predictor for peripheral compression neuropathies, a registry-based study
Olsson, C., Rydberg, M., & Zimmerman, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275598 · Cited by 6
Li, X., Pu, R., Zhang, Q., Guo, Q., Liu, J., & Li, H. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-22-1049 · Cited by 6
Principles of Pharmacogenomics and Pharmacogenetics
Hasanzad, M., Sarhangi, N., Hashemian, L., & Sarrami, B. (2022) · Springer eBooks · doi:10.1007/978-981-19-5082-7_2 · Cited by 9
Lü, B., Sun, J., Chen, L., Song, X., Deng, Y., Dong, Y., Dong, J., Du, P., Ge, J., Guo, Y., et al. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.01.003 · Cited by 6
Shanahan, J. L., Vimalananda, V. G., Graham, L. A., Schumann, R., & Mull, H. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.6318 · Cited by 6
Zhang, T., Wang, X., Zhang, Y., Yang, Y., Yang, C., Wei, H., & Zhao, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04245-w · Cited by 7
Yang, S., Yang, J., Gong, X., Weiss, M. A., & Strano, M. S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300587 · Cited by 6
Block, C. E. M. D., CHENG, A. Y. Y., Christensen, T. B., Patted, U. R. H., & Ginovker, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01429-x · Cited by 8
Hall, B., Żebrowska, A., Sikora, M., Siatkowski, S., & Robins, A. (2023) · Nutrients · doi:10.3390/nu15173749 · Cited by 7
Hollander, P. A., Krause-Steinrauf, H. J., Butera, N. M., Kazemi, E. J., Ahmann, A., Fattaleh, B. N., Johnson, M. L., Killean, T., Lagari, V. S., Larkin, M., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0516 · Cited by 6
Analysis of the management and therapeutic performance of diabetes mellitus employing special target
Sun, H., & Lin, X.-Y. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1721 · Cited by 8
Werkman, N. C. C., García-Sáez, G., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W., Kallen, C., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06082-4 · Cited by 6
Abose, A., Getachew, A., Obsa, F., Bekele, S., Haile, K., & Abose, S. (2024) · African Health Sciences · doi:10.4314/ahs.v24i1.23 · Cited by 6
Azeez, T. A. (2021) · Journal of Advances in Internal Medicine · doi:10.3126/jaim.v10i1.37090 · Cited by 6
Abdissa, D., Sorsa, R., Gerbi, A., Hamba, N., & Banjaw, Z. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08460 · Cited by 7
Impacto de la actividad física en la variabilidad glucémica en personas con diabetes mellitus tipo 2
Astrid von Oetinger, G., Gittermann, L. M. T., & Soto, N. (2021) · Rehabilitación · doi:10.1016/j.rh.2020.11.004 · Cited by 7
Zabolotskikh, I. B., Malyshev, Y. P., Вадимович, Д. П., Лебединский, К. М., Лейдерман, И. Н., Неймарк, М. И., Semenikhina, Т. М., & Yaroshetskiy, A. I. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-1-14-33 · Cited by 7
Benhamou, P., Adenis, A., Lablanche, S., Franc, S., Amadou, C., Penfornis, A., Kariyawasam, D., Beltrand, J., & Charpentier, G. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231186976 · Cited by 6
Mané, D. I., Demba, D., Sow, D., Assane, N. M., Limane, B. A., Marie, K.-C., Anna, S., & Maimouna, N.-M. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.209.18524 · Cited by 6
Kataoka, Y., Hosoda, K., Makino, H., Matsubara, M., Matsuo, M., Ohata, Y., Koezuka, R., Tamanaha, T., Tomita, T., Honda-Kohmo, K., et al. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.09.02 · Cited by 6
Cahyaningsih, I., Rokhman, M. R., Maziyyah, N., Niamuzisilawati, E., Taxis, K., & Denig, P. (2024) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106241287445 · Cited by 5
Joubert, N., Adams, L., Hattendorf, J., Degen, J., Dolley, D., Gresse, A., Müller, I., Nqweniso, S., Probst-Hensch, N. M., Seelig, H., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004681 · Cited by 5
Diabetes Mellitus in Pregnancy: Implications for Obstetric Anesthesia
Rogers, W. K., Chugaieva, I., Moheet, A. A., & Wernimont, S. A. (2025) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0001192196.21020.41 · Cited by 6
Song, Y., Lyu, S., Wang, R., Hou, X., Tong, X., Fang, Y., Zhang, Z., Liu, A., Yang, M. G., Li, Y., et al. (2025) · NanoImpact · doi:10.1016/j.impact.2025.100590 · Cited by 5
Poor glycemic control in bariatric patients: a reason to delay or a reason to proceed?
Mazzei, M. M., & Edwards, M. A. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.022 · Cited by 5
Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score)
Kijprasert, W., Tarudeeyathaworn, N., Loketkrawee, C., Pimpaporn, T., Pattarasettaseranee, P., & Tangsuwanaruk, T. (2022) · BMC Emergency Medicine · doi:10.1186/s12873-022-00748-9 · Cited by 7
Supporting the Use of a Person’s Own Diabetes Technology in the Inpatient Setting
Pattison, J., Dungan, K. M., & Faulds, E. R. (2022) · Diabetes Spectrum · doi:10.2337/dsi22-0011 · Cited by 5
Pei, Y., Ke, W., Lü, J., Lin, Y., Zhang, Z., Peng, Y., Bi, Y., Li, Y., Hou, J., Zhang, X., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0234 · Cited by 5
dos Santos, D. N. D., Coelho, C. G., Diniz, M. D. F. H. S., Duncan, B. B., Schmidt, M. I., Benseñor, I. M., Szlejf, C., Telles, R. W., & Barreto, S. M. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen081223 · Cited by 5
Schütz, A. K., Rami-Merhar, B. M., Schütz-Fuhrmann, I., Blauensteiner, N., Baumann, P. M., Pöttler, T., & Mader, J. K. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241230106 · Cited by 6
Moreno, E. V., Ortiz, M. T. A., Sánchez, F. J., García‐Palacios, A., Monreal‐Bartolomé, A., Gili, M., García‐Campayo, J., & Mayoral, F. (2024) · JMIR mhealth and uhealth · doi:10.2196/55483 · Cited by 6
Liu, Z., Lin, B., Chen, D., Yang, Y., Jiang, W., Yang, D., Yan, J., Yao, B., Yang, X., & Xu, W. (2024) · Endocrine · doi:10.1007/s12020-024-04083-w · Cited by 6
Joshi, N., Baloch, K., Rukh, S., Khan, A. M., Muskan, F., Kumari, V., Khan, H., Zeeshan, M., Azam, G., Khalid, S., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002712 · Cited by 5
Ren, H., Hu, M., Yan, Y., Cheng, M., Yang, C., Yuan, G., & Du, T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112927 · Cited by 5
Scarberry, K. A., Thomas, G. M., Cowper, M. G., Chouhan, J. D., Thakker, P. U., Matz, E., Dutta, R., & Terlecki, R. P. (2020) · Urology · doi:10.1016/j.urology.2020.09.004 · Cited by 5
Li, L., Lip, G. Y. H., Li, S., Adachi, J. D., Thabane, L., & Li, G. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01567-9 · Cited by 5
Continuous Glucose Monitoring: Optimizing Diabetes Care: Executive Summary
Miller, E. M., Gavin, J. R., Kruger, D. F., & Brunton, S. (2022) · Clinical Diabetes · doi:10.2337/cd22-0043 · Cited by 6
Mahmoud, M. I., Alotaibi, R., Almusally, R. M., Shafiek, H., Elamin, Y., Alhaj, Z., Albaker, W. I., Elfaki, A., Qutub, H. O., Albahrani, S. J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020617 · Cited by 5
Zhang, N., Wen, K., Liu, Y., Huang, W., Liang, X., & Liang, L. (2022) · Cornea · doi:10.1097/ico.0000000000003116 · Cited by 5
Type 1 Diabetes Overview and Perioperative Management
Nelson, G., & Sumpter, K. (2023) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2023.02.001 · Cited by 5
Ji, L., Luo, Y., Bee, Y. M., Xia, J., Nguyen, K. T., Zhao, W., Chen, L., Chan, S. P., Deerochanawong, C., Lim, S. K., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13392 · Cited by 4
The trend of achieving ABC goals in patients with type 2 diabetes between 2010-2014 and 2015–2019
Tavakoli, M., Seifouri, S., Seifouri, K., Reyhan, S. K., Rajab, A., Esteghamati, A., Nakhjavani, M., & Rabizadeh, S. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100498 · Cited by 5
Sempere‐Bigorra, M., Julían-Rochina, I., Pérez‐Ros, P., Navarro‐Flores, E., Martínez‐Arnau, F. M., & Cauli, O. (2023) · Life · doi:10.3390/life13091790 · Cited by 5
Guo, L., Li, L., Yu, Q., Wang, N., Chen, J., Xi, Y., Wang, H., Wang, Y., & Xu, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15252 · Cited by 5
Fundamentos de la hemoglobina glicada. Valor y ventajas en la práctica clínica
Camarena-Hidalgo, M. S., Meaney, E., & Ortiz-Vilchis, P. (2023) · Cardiovascular and Metabolic Science · doi:10.35366/112761 · Cited by 5
Melander, S. A., Larsen, A. T., Karsdal, M. A., & Henriksen, K. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16329 · Cited by 5
Aldahmani, K. M., Suliman, M., Hafidh, K., & Beshyah, S. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1786013 · Cited by 5
Johansson, U., Gleissman, S. A., Lidén, M. K., Wickman, M., Gustafsson, B., & Sjöberg, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29498 · Cited by 6
Chen, Y., Miao, Y., & Zhang, Q. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07126-0 · Cited by 5
Diawara, A., Coulibaly, D. M., Fofana, F. G., Koné, D., Traore, M. A., Bazi, D. S., Kassogué, O., Sylla, D., Diabaté, O., Sangaré, M., et al. (2024) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2024.142012 · Cited by 5
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S83-S96
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200358162
- Semantic Scholar
- a2d5992c30a9e8b02214ffbd9d329cfbb3094b63
- Cited by
- 1,403
- References
- 135
- Citations by year
- 2026: 70 · 2025: 158 · 2024: 246 · 2023: 369 · 2022: 273 · 2021: 126
- FWCI
- 38.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, diabetes management, glycemic control, clinical guidelines, quality of care
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
